{"nct_id":"NCT05795153","title":"A Multicenter, Open-label Phase 3 Study: Ambulatory Blood Pressure Monitoring in Adult Patients With Chronic Spontaneous Urticaria Inadequately Controlled by H1-antihistamines Treated With Remibrutinib up to 12 Weeks.","status":"COMPLETED","status_verified_date":"2025-04","start_date":"2023-04-05","start_date_type":"ACTUAL","primary_completion_date":"2024-04-25","primary_completion_date_type":"ACTUAL","completion_date":"2024-04-25","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}